Johnson & Johnson to Participate in the Goldman Sachs 44th Annual Global Healthcare Conference Pharmaceutical Investing
Goodness Growth Holdings to Release First Quarter 2023 Results on May 15, 2023 Psychedelics Investing
CSE Bulletin: Suspensions - ADMT, ABRT, CFT, GAIA, IWIN, PKG, POLE, PRTI, RWB, CALM, RVR, VEJI Pharmaceutical Investing
Knight to Present at the 2023 RBC Capital Markets Global Healthcare Conference in New York City Pharmaceutical Investing
AMGEN AND TSCAN THERAPEUTICS ANNOUNCE COLLABORATION TO IDENTIFY NOVEL TARGETS IN CROHN'S DISEASE Market News
Gilead Strengthens Early Pipeline in Oncology and Inflammation Through the Acquisition of XinThera Life Science Investing
Thermo Fisher Scientific & Pfizer Partner to Expand Localized Access to Next-Generation Sequencing-Based Testing for Cancer Patients in International Markets Medical Device Investing
Health Canada Approves AbbVie's RINVOQ® for the Treatment of Adults with Active Non-Radiographic Axial Spondyloarthritis Life Science Investing
Aurinia Pharmaceuticals Announces Kidney Biopsies Sub-study Data from the LUPKYNIS® AURORA 2 Clinical Trial Presented at Congress of Clinical Rheumatology East Conference Life Science Investing
MindBio Therapeutics Corp (CSE:MBIO) Lists Its Common Shares On The Canadian Securities Exchange Psychedelics Investing
